{
     "PMID": "24316471",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20140911",
     "LR": "20140122",
     "IS": "1873-7544 (Electronic) 0306-4522 (Linking)",
     "VI": "259",
     "DP": "2014 Feb 14",
     "TI": "Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.",
     "PG": "223-31",
     "LID": "10.1016/j.neuroscience.2013.11.049 [doi] S0306-4522(13)00996-2 [pii]",
     "AB": "Supplementation with omega-3 has been identified as an adjunctive alternative for the treatment of psychiatric disorders, in order to minimize symptoms. Considering the lack of understanding concerning the pathophysiology of schizophrenia, the present study hypothesized that omega 3 prevents the onset of symptoms similar to schizophrenia in young Wistar rats submitted to ketamine treatment. Moreover, the role of oxidative stress in this model was assessed. Omega-3 (0.8g/kg) or vehicle was given by orogastric gavage once daily. Both treatments were performed during 21days, starting at the 30th day of life in young rats. After 14days of treatment with omega-3 or vehicle, a concomitant treatment with saline or ketamine (25mg/kg ip daily) was started and maintained until the last day of the experiment. We evaluated the pre-pulse inhibition of the startle reflex, activity of antioxidant systems and damage to proteins and lipids. Our results demonstrate that supplementation of omega-3 prevented: decreased inhibition of startle reflex, damage to lipids in the hippocampus and striatum and damage to proteins in the prefrontal cortex. Furthermore, these changes are associated with decreased GPx in brain tissues evaluated. Together, our results suggest the prophylactic role of omega-3 against the outcome of symptoms associated with schizophrenia.",
     "CI": [
          "Copyright (c) 2014. Published by Elsevier Ltd."
     ],
     "FAU": [
          "Zugno, A I",
          "Chipindo, H L",
          "Volpato, A M",
          "Budni, J",
          "Steckert, A V",
          "de Oliveira, M B",
          "Heylmann, A S",
          "da Rosa Silveira, F",
          "Mastella, G A",
          "Maravai, S G",
          "Wessler, P G",
          "Binatti, A R",
          "Panizzutti, B",
          "Schuck, P F",
          "Quevedo, J",
          "Gama, C S"
     ],
     "AU": [
          "Zugno AI",
          "Chipindo HL",
          "Volpato AM",
          "Budni J",
          "Steckert AV",
          "de Oliveira MB",
          "Heylmann AS",
          "da Rosa Silveira F",
          "Mastella GA",
          "Maravai SG",
          "Wessler PG",
          "Binatti AR",
          "Panizzutti B",
          "Schuck PF",
          "Quevedo J",
          "Gama CS"
     ],
     "AD": "Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil. Electronic address: alz@unesc.net. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Psiquiatria Molecular, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil. Laboratorio de Psiquiatria Molecular, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20131204",
     "PL": "United States",
     "TA": "Neuroscience",
     "JT": "Neuroscience",
     "JID": "7605074",
     "RN": [
          "0 (Fatty Acids, Omega-3)",
          "0 (Thiobarbituric Acid Reactive Substances)",
          "4Y8F71G49Q (Malondialdehyde)",
          "690G0D6V8H (Ketamine)",
          "EC 1.11.1.9 (Glutathione Peroxidase)",
          "EC 1.15.1.1 (Superoxide Dismutase)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain/drug effects/metabolism",
          "Brain Injuries/*diet therapy/*etiology",
          "Disease Models, Animal",
          "Dose-Response Relationship, Drug",
          "Fatty Acids, Omega-3/*administration & dosage",
          "Glutathione Peroxidase/metabolism",
          "Ketamine/toxicity",
          "Male",
          "Malondialdehyde/metabolism",
          "Mental Disorders/etiology/*prevention & control",
          "Oxidative Stress/drug effects",
          "Protein Carbonylation/drug effects",
          "Rats",
          "Rats, Wistar",
          "Schizophrenia/chemically induced/*complications/pathology",
          "Sensory Gating/drug effects",
          "Superoxide Dismutase/metabolism",
          "Thiobarbituric Acid Reactive Substances/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "ANOVA",
          "BDNF",
          "Brain-derived neurotrophic factor",
          "CAT",
          "DHA",
          "DNPH",
          "EDTA",
          "EPA",
          "GPx",
          "GSH",
          "NADPH",
          "PUFAs",
          "ROS",
          "SOD",
          "TBARS",
          "analysis of variance",
          "antioxidants",
          "catalase",
          "dihydronicotinamide-adenine dinucleotide phosphate",
          "dinitrophenylhydrazine",
          "docosahexaenoic acid",
          "eicosapentaenoic acid",
          "ethylenediaminetetraacetic acid",
          "glutathione",
          "glutathione peroxidase",
          "ketamine",
          "omega 3",
          "polyunsaturated fatty acids",
          "prepulse inhibition",
          "reactive oxygen species",
          "schizophrenia",
          "superoxide dismutase",
          "thiobarbituric acid reactive species"
     ],
     "EDAT": "2013/12/10 06:00",
     "MHDA": "2014/09/12 06:00",
     "CRDT": [
          "2013/12/10 06:00"
     ],
     "PHST": [
          "2013/07/08 00:00 [received]",
          "2013/10/31 00:00 [revised]",
          "2013/11/22 00:00 [accepted]",
          "2013/12/10 06:00 [entrez]",
          "2013/12/10 06:00 [pubmed]",
          "2014/09/12 06:00 [medline]"
     ],
     "AID": [
          "S0306-4522(13)00996-2 [pii]",
          "10.1016/j.neuroscience.2013.11.049 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuroscience. 2014 Feb 14;259:223-31. doi: 10.1016/j.neuroscience.2013.11.049. Epub 2013 Dec 4.",
     "term": "hippocampus"
}